Non-invasive radiotracer imaging as a tool for drug development.
about
Synthesis, structure-affinity relationships, and radiolabeling of selective high-affinity 5-HT4 receptor ligands as prospective imaging probes for positron emission tomographySynthesis and evaluation of radioligands for imaging brain nociceptin/orphanin FQ peptide (NOP) receptors with positron emission tomographyEvaluation in monkey of two candidate PET radioligands, [(11) C]RX-1 and [(18) F]RX-2, for imaging brain 5-HT4 receptorsFunctional imaging of physiological processes by positron emission tomography.Rapid and Efficient Radiosyntheses of Meta-substituted [F]Fluoroarenes from [F]Fluoride Ion and Diaryliodonium Tosylates within a Microreactor.Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: distribution in tissue.Synthesis and structure-affinity relationships of selective high-affinity 5-HT(4) receptor antagonists: application to the design of new potential single photon emission computed tomography tracers.First-in-human phase 0 trial of oral 5-iodo-2-pyrimidinone-2'-deoxyribose in patients with advanced malignancies.Radiofluorination of diaryliodonium tosylates under aqueous-organic and cryptand-free conditionsCan Ketones Help Rescue Brain Fuel Supply in Later Life? Implications for Cognitive Health during Aging and the Treatment of Alzheimer's DiseaseSynthesis of a potent and selective (18)F-labeled delta-opioid receptor antagonist derived from the Dmt-Tic pharmacophore for positron emission tomography imaging.Can ketones compensate for deteriorating brain glucose uptake during aging? Implications for the risk and treatment of Alzheimer's disease.Asymmetric 18F-fluorination for applications in positron emission tomography.A caspase active site probe reveals high fractional inhibition needed to block DNA fragmentation.Bayesian hierarchical modeling of receptor occupancy in PET trials.
P2860
Q24633892-40068D9D-F70E-444E-AB03-5DE690223330Q34842096-AFFECFC0-B85C-40A9-8B99-B5650236E458Q35050159-99057078-42F7-44E8-9D6F-98FE4AAD8CB1Q35180287-3CA5F926-9477-4199-94C3-77083B74941AQ35369805-1F6FAE23-E6AB-449B-B3A2-68DD0FB2BC15Q35754443-8573D078-7A1F-453A-90E0-F06566109696Q36431626-8462A402-CDE1-44A5-B303-FE226C302378Q36856248-8B254676-E404-47F4-B429-001A6D9BDB02Q37056100-BCBA6F52-CF6D-4178-9701-67ED0AB2F32EQ37075513-8218FECE-8CFB-4939-9900-2A5EB56F407CQ37153933-4F0A09E2-CDCC-4B25-8FDD-D27C78B95261Q38696404-0335B730-AFBA-4A70-9805-E4E1DAE37369Q41174141-8E56379D-D44C-4F87-B657-ADF6B959966FQ47810902-354A3628-A8D8-4640-9E7E-46575AEC1096Q51891389-3460F9F6-7465-4FC1-89A8-45DD4292DA01
P2860
Non-invasive radiotracer imaging as a tool for drug development.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Non-invasive radiotracer imaging as a tool for drug development.
@ast
Non-invasive radiotracer imaging as a tool for drug development.
@en
type
label
Non-invasive radiotracer imaging as a tool for drug development.
@ast
Non-invasive radiotracer imaging as a tool for drug development.
@en
prefLabel
Non-invasive radiotracer imaging as a tool for drug development.
@ast
Non-invasive radiotracer imaging as a tool for drug development.
@en
P2093
P356
P1476
Non-invasive radiotracer imaging as a tool for drug development.
@en
P2093
P304
P356
10.2174/1381612003399987
P577
2000-07-01T00:00:00Z